Research prototype, not medical advice.

Roadmap

The project's goals are written as obstacles: what stands between us and the goal. Each has an owner, an exit (what counts as taking it down) and a date. Verification, not the owner, decides when an exit is met.

Dates are compared with October 22, 2026, the day of the latest change. No obstacle is past its date.

Timeline

One row per obstacle. Bar: from today to the exit date. Square: exit. Diamond: intermediate milestone. Red: date passed and not closed. Click a row to open its file.

Oct2026NovDecJan2027FebMarAprMayJunJulAugSepOctNovV4: 13 procedure rules undecided (exit 2026-10-20)V4O13: Results that can't be reproduced (exit 2026-11-20)O13O14: Gates that rely on trust (shared token, D68 refused) (exit 2026-11-20)O14O15: Data too big for git (exit 2026-11-20)O15O16: No public route to SLAM longitudinal data (exit 2026-11-20)O16O9: Data access (exit 2026-11-20)O9V2: Hidden keys (planted errors, adversarial cases, held-out mice) not isolated (exit 2026-11-20)V2O11: Published lifespan effects are biased (sick controls, unpublished nulls) (exit 2027-01-20)O11O12: Causal links asserted without refutation tests (exit 2027-01-20)O12V1: No blind test exists yet: every score so far is retrospective (T1-A50-3) (exit 2027-01-20)V1O1: No measure that reads ageing reliably (exit 2027-04-20)O1O1: 'A12 blood counts: no right-way control (blind-spot under O1)' (exit 2027-04-20)O1O1: 'A15 fat mass: no right-way control (blind-spot under O1)' (exit 2027-04-20)O1O1: 'A8 lung function: no right-way control (blind-spot under O1)' (exit 2027-04-20)O1O1: 'A9 kidney GFR/albuminuria: no mouse right-way control (blind-spot under O1)' (exit 2027-04-20)O1O1: 'H11 plasma inflammation (IL-6/TNF): no right-way control (blind-spot under O1)' (exit 2027-04-20)O1O6: Strain and sex dependence (exit 2027-04-20)O6O8: No mice, lab or budget (exit 2027-04-20)O8V3: Scorecards checked only by re-running the same code (exit 2027-04-20)V3O2: Causes not separated from consequences (exit 2027-07-20)O2O3: Cancer ceiling (exit 2027-07-20)O3O5: 3 years per lifespan test (exit 2027-07-20)O5O7: Combined toxicity (exit 2027-07-20)O7O10: Long-lived species unexplained (exit 2027-10-20)O10O4: Combinations don't add up (exit 2027-10-20)O4today

All obstacles

#ObstacleOwnerExitDateStatus
V4 13 procedure rules undecided
Charter: done (D120, adopted at session 1 close, c24b135). A50 confirms.
A50 -> chair Decided in session 1 (T7-A50-2) October 20, 2026 Exit met
O13 Results that can't be reproduced
After month 1 the exit is ongoing: every sealed prediction re-runs before sealing.
A10 Run manifests + one seeded re-run in CI (month 1); then every sealed prediction and published number re-runs from its manifest before sealing November 20, 2026 Open
O14 Gates that rely on trust (shared token, D68 refused)
Evidence = M2 batch merge hash + first green drift-job run. Date set by A10 (month 1).
A10 M2 batch merged; drift job live with the president's read-only token; seal covers workflows and scripts November 20, 2026 Open
O15 Data too big for git
Switch check to the P1 file-size job once it lands.
A10 Every T5 source with known access fetched by manifest; no committed file > 10 MB outside the allow-list November 20, 2026 Open
O16 No public route to SLAM longitudinal data A2 A confirmed route with licence (A9/A50), or a written request sent to the NIA programme with metric v0's plan attached November 20, 2026 Open
O9 Data access A9 + A50 Every T5 source fetched by manifest with its licence recorded November 20, 2026 Open
V2 Hidden keys (planted errors, adversarial cases, held-out mice) not isolated
Judged by A1, not A50 (D55).
A50 -> president Keys in a GitHub Actions environment that needs the president's approval to read November 20, 2026 Open
O11 Published lifespan effects are biased (sick controls, unpublished nulls) A2 L1 complete with T1-A2-3 flags; share of flagged results reported January 20, 2027 Open
O12 Causal links asserted without refutation tests
T8 said 'before sim v0 calibration'; charter part 9 dates it month 3.
A2 L3 row with its refuting experiment for every sim v0 edge and mapping, approved by A50 January 20, 2027 Open
V1 No blind test exists yet: every score so far is retrospective (T1-A50-3)
Judged by A1, not A50 (D55).
A50 + A28 >= 10 sealed forecasts on not-yet-public results, criteria approved January 20, 2027 Open
O1 No measure that reads ageing reliably A28 + A50 Metric v0 passes T1 tests 1-4 on public data; tests 5-6 reported April 20, 2027 Open
O1 'A12 blood counts: no right-way control (blind-spot under O1)' A28 An intervention that corrects an aged complete blood count is found (dietary restriction itself induces lymphopenia, moving it "older"; old B6 marrow repopulates better than young); closed individually when a right-way control is found April 20, 2027 Open
O1 'A15 fat mass: no right-way control (blind-spot under O1)' A28 A late-life intervention acting on the non-monotonic fat-mass trajectory is found (A15 is non-monotonic, so lower fat in an old mouse is not a pass); closed individually when a right-way control is found April 20, 2027 Open
O1 'A8 lung function: no right-way control (blind-spot under O1)' A28 A right-way aged-mouse lung readout control is found (compliance rises with age, so "restored compliance" is not a pass); closed individually when a right-way control is found April 20, 2027 Open
O1 'A9 kidney GFR/albuminuria: no mouse right-way control (blind-spot under O1)' A28 A mouse intervention that lowers aged albuminuria or raises GFR is found (right-way evidence is rat-only; 50% CR in B6 moved histology, not GFR/albuminuria); closed individually when a right-way control is found April 20, 2027 Open
O1 'H11 plasma inflammation (IL-6/TNF): no right-way control (blind-spot under O1)' A28 An intervention that lowers aged plasma IL-6/TNF is found (only tissue effects found - liver p65, ex-vivo macrophage; plasma readout unmet); closed individually when a right-way control is found April 20, 2027 Open
O6 Strain and sex dependence
Milestone, February 20, 2027: Sex transfer stratum sealed
Dated by owners in G160. Strain transfer before any claim stays ongoing after the exit date.
A28 + A50 Metric v0 scorecard reported per sex; strain transfer tested before any claim (ongoing after this date) April 20, 2027 Open
O8 No mice, lab or budget A1 First request sent with O1's scorecard attached April 20, 2027 Open
V3 Scorecards checked only by re-running the same code
Milestone, December 20, 2026: recompute plan + 2nd-implementation spec
Dated by A50 (PR #51, 161772a). Judged by A1, not A50 (D55).
A50 Independent recompute of tests 2 and 4 for metric v0 (T1-A50-4) April 20, 2027 Open
O2 Causes not separated from consequences
Milestone, February 20, 2027: Sim v0 calibrated on ITP controls; null model (T2-A50-1) and test strata (T2-A28-6) sealed
A28 + A2 Model's in-silico interventions match >= 80% of test-set effects in direction and lie within the noise ceiling in size July 20, 2027 Open
O3 Cancer ceiling
Milestone, April 20, 2027: Necropsy cause-of-death table (T4-A2-1) loaded; model's cause-of-death output compared on controls
A28 (module), A2 (evidence) Model reproduces causes of death at necropsy in control mice July 20, 2027 Open
O5 3 years per lifespan test
Milestone, March 20, 2027: First early-reading -> remaining-lifespan score on held-out mice from public longitudinal data
A28 A metric reading at 6-12 months predicts final lifespan in held-out mice (T1 test 4, read early) July 20, 2027 Open
O7 Combined toxicity
Milestone, April 20, 2027: Adverse findings and worsened axes for every O4 combination
Dated by owners in G160. Co-owners A28 (module) + A2 (evidence).
A28 + A2 Toxicity check for every candidate combination before a request July 20, 2027 Open
O10 Long-lived species unexplained
Milestone, April 20, 2027: First L3 rows on naked mole-rat and bat cancer resistance, with the T1 axes they touch
A2 + A28 Comparative module lists which T1 axes differ in naked mole-rat and bats October 20, 2027 Open
O4 Combinations don't add up
Milestone, April 20, 2027: List of published combination studies (L1) with sealed sim forecasts for each
A28 Model predicts published combination studies (e.g. rapamycin + acarbose) within their intervals October 20, 2027 Open